Mark K. Meiselbach

473 total citations
51 papers, 300 citations indexed

About

Mark K. Meiselbach is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Mark K. Meiselbach has authored 51 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Economics and Econometrics, 31 papers in General Health Professions and 9 papers in Epidemiology. Recurrent topics in Mark K. Meiselbach's work include Healthcare Policy and Management (34 papers), Global Health Care Issues (15 papers) and Primary Care and Health Outcomes (14 papers). Mark K. Meiselbach is often cited by papers focused on Healthcare Policy and Management (34 papers), Global Health Care Issues (15 papers) and Primary Care and Health Outcomes (14 papers). Mark K. Meiselbach collaborates with scholars based in United States, Switzerland and Italy. Mark K. Meiselbach's co-authors include Daniel Polsky, Gerard F. Anderson, Yang Wang, Ge Bai, Jane M. Zhu, Coleman Drake, Aditi P. Sen, Matthew D. Eisenberg, Elyse Swallow and Kelly E. Anderson and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Mark K. Meiselbach

41 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark K. Meiselbach United States 11 159 130 50 43 28 51 300
Aixia Ma China 8 115 0.7× 99 0.8× 29 0.6× 37 0.9× 19 0.7× 19 298
Christelle Gastaldi‐Ménager France 10 70 0.4× 72 0.6× 38 0.8× 76 1.8× 23 0.8× 23 314
Deanna B. McQuillan United States 8 111 0.7× 190 1.5× 39 0.8× 123 2.9× 18 0.6× 12 332
Jiaoling Huang China 10 108 0.7× 125 1.0× 29 0.6× 57 1.3× 11 0.4× 47 322
Néboa Zozaya Spain 10 106 0.7× 96 0.7× 49 1.0× 36 0.8× 20 0.7× 45 372
Sophia Eilat‐Tsanani Israel 11 64 0.4× 158 1.2× 69 1.4× 68 1.6× 20 0.7× 33 308
Rosanna Orlando United Kingdom 10 60 0.4× 91 0.7× 44 0.9× 62 1.4× 38 1.4× 21 293
Laura A. Gray United Kingdom 9 134 0.8× 71 0.5× 78 1.6× 21 0.5× 19 0.7× 25 330
Thomas Grischott Switzerland 9 181 1.1× 51 0.4× 51 1.0× 20 0.5× 17 0.6× 27 344
Zhengyi Fang United States 9 249 1.6× 87 0.7× 51 1.0× 70 1.6× 12 0.4× 13 392

Countries citing papers authored by Mark K. Meiselbach

Since Specialization
Citations

This map shows the geographic impact of Mark K. Meiselbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Meiselbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Meiselbach more than expected).

Fields of papers citing papers by Mark K. Meiselbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Meiselbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Meiselbach. The network helps show where Mark K. Meiselbach may publish in the future.

Co-authorship network of co-authors of Mark K. Meiselbach

This figure shows the co-authorship network connecting the top 25 collaborators of Mark K. Meiselbach. A scholar is included among the top collaborators of Mark K. Meiselbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark K. Meiselbach. Mark K. Meiselbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meiselbach, Mark K., et al.. (2026). Social Risk Adjustment and Bonus Eligibility in Medicare Advantage Star Ratings. JAMA Health Forum. 7(3). e260326–e260326.
2.
Meiselbach, Mark K., et al.. (2026). Forced Disenrollments Among Medicare Advantage Beneficiaries Following 2026 Plan Exits. JAMA. 335(10). 907–907.
3.
Ettman, Catherine K., et al.. (2024). Financial assets and mental health over time. Scientific Reports. 14(1). 27370–27370. 3 indexed citations
4.
Drake, Coleman, et al.. (2024). Racial and Ethnic Disparities in Geographic Availability of Buprenorphine. Journal of Addiction Medicine. 18(3). 335–338. 3 indexed citations
5.
Kennedy‐Hendricks, Alene, Mark K. Meiselbach, Elizabeth A. Stuart, et al.. (2024). Changes in Healthcare Spending Attributable to High Deductible Health Plan Offer Among Enrollees with Comorbid Substance Use Disorder and Cardiovascular Disease. Journal of General Internal Medicine. 39(11). 1993–2000.
6.
Meiselbach, Mark K., et al.. (2024). Unmet need for mental health care is common across insurance market segments in the United States. Health Affairs Scholar. 2(3). qxae032–qxae032. 3 indexed citations
7.
Wang, Yang, et al.. (2024). Commercial insurers' market power and hospital prices in Medicaid managed care. Health Services Research. 60(1). e14407–e14407. 1 indexed citations
8.
Meiselbach, Mark K. & Jean Abraham. (2023). Do minimum wage laws affect employer-sponsored insurance provision?. Journal of Health Economics. 92. 102825–102825. 1 indexed citations
9.
Cram, Peter, et al.. (2023). Comparison of social determinants of health in Medicaid vs commercial health plans. Health Affairs Scholar. 1(6). qxad074–qxad074. 10 indexed citations
10.
Wang, Yang, et al.. (2023). Hospital Prices in Medicaid Managed Care. JAMA Network Open. 6(11). e2344841–e2344841. 4 indexed citations
11.
Anderson, Gerard F. & Mark K. Meiselbach. (2023). Why Are Some Value-Based Programs Successful?. JAMA Network Open. 6(3). e234412–e234412. 1 indexed citations
12.
Kennedy‐Hendricks, Alene, Mark C. Bicket, Mark K. Meiselbach, et al.. (2023). Impact of High Deductible Health Plans on U.S. Adults With Chronic Pain. American Journal of Preventive Medicine. 65(5). 800–808. 3 indexed citations
13.
Meiselbach, Mark K., Alene Kennedy‐Hendricks, Alisa B. Busch, et al.. (2022). High deductible health plans and spending among families with a substance use disorder. Drug and Alcohol Dependence. 241. 109681–109681. 4 indexed citations
14.
Sen, Aditi P., Yashaswini Singh, Mark K. Meiselbach, Matthew D. Eisenberg, & Gerard F. Anderson. (2021). Participation, Pricing, and Enrollment in a Health Insurance “Public Option”: Evidence From Washington State's Cascade Care Program. Milbank Quarterly. 100(1). 190–217. 6 indexed citations
15.
Kennedy‐Hendricks, Alene, Alisa B. Busch, Elizabeth A. Stuart, et al.. (2021). Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder. Journal of General Internal Medicine. 37(4). 769–776. 7 indexed citations
16.
McInerney, Melissa & Mark K. Meiselbach. (2020). Distributional Effects of Recent Health Insurance Expansions on Weight-Related Outcomes. Economics & Human Biology. 38. 100870–100870. 2 indexed citations
17.
Deschamps, Marie, Mark K. Meiselbach, Christian Perodin, et al.. (2019). Characteristics and Psychological Consequences of Sexual Assault in Haiti. Violence and Gender. 6(2). 124–130. 3 indexed citations
18.
19.
Dell’Agnello, Grazia, Urvi Desai, Noam Y. Kirson, et al.. (2018). Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England. BMJ Open. 8(3). e019684–e019684. 6 indexed citations
20.
Vogelzang, Nicholas J., Sumanta K. Pal, Sameer R. Ghate, et al.. (2017). Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis. Advances in Therapy. 34(11). 2452–2465. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aixia Ma Breakdown of academic impact, for papers by Christelle Gastaldi‐Ménager Breakdown of academic impact, for papers by Deanna B. McQuillan Breakdown of academic impact, for papers by Jiaoling Huang Breakdown of academic impact, for papers by Néboa Zozaya Breakdown of academic impact, for papers by Sophia Eilat‐Tsanani Breakdown of academic impact, for papers by Rosanna Orlando Breakdown of academic impact, for papers by Laura A. Gray Breakdown of academic impact, for papers by Thomas Grischott Breakdown of academic impact, for papers by Zhengyi Fang
Rankless by CCL
2026